The firm is investigating potential claims against the board of directors of Chemed Corp. (CHE) concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws.
Chemed Corp. (CHE), a Delaware corporation headquartered in Cincinnati, Ohio, operates in the healthcare, and repair and maintenance fields in the United States. The company operates in two segments, Vitas and Roto-Rooter. The Vitas segment offers hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
The company has paid bonuses to employees based on the number of patients enrolled in crisis care and took adverse employment actions against employees who didnít meet related quotas, and has repeatedly violated the False Claims Act, misspending tens of millions of taxpayer money. On May 2, 2013, the US DOJ filed suit against Chemed/Vitus subs, alleging false Medicare billings for hospice services. Various qui tam actions and the governmentís investigation revealed that the company knowingly submitted false claims to Medicare for crisis care services that were not necessary, not provided, or for people who were not terminally ill.
If you are aware of any facts relating to this investigation, or are a current shareholder since November 2011 and would like to discuss your options of exercising your rights as a shareholder, please contact us.
Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.
Please Note: Neither the submission to nor the receipt of information by The Law Offices of Marc S. Henzel or one of its attorneys through this website constitutes an agreement by the firm to represent the individual and does not create an attorney-client relationship.